Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer. (15th February 2021)
- Record Type:
- Journal Article
- Title:
- Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer. (15th February 2021)
- Main Title:
- Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer
- Authors:
- Shi, Xiaoqun
Yang, Xiaoye
Liu, Mengyao
Wang, Rujuan
Qiu, Na
Liu, Yuanxiu
Yang, Haotong
Ji, Jianbo
Zhai, Guangxi - Abstract:
- Highlights: Novel chondroitin sulfate-based nanoparticles (PTX/CQE NPs) were initially prepared. PTX/CQE NPs could exert enhanced chemo-photodynamic therapy in vitro and in vivo . PTX/CQE NPs exhibited in vivo MDR inhibition and anti-metastasis efficacy. Abstract: As a major therapeutic approach for cancer treatment, the effectiveness of chemotherapy is challenged by multidrug resistance (MDR). Herein, we fabricated novel redox-responsive, chondroitin sulfate-based nanoparticles that could simultaneously deliver quercetin (chemosensitizer), chlorin e6 (photosensitizer) and paclitaxel (chemotherapeutic agent) to exert enhanced chemo-photodynamic therapy for overcoming MDR and lung metastasis of breast cancer. In vitro cell study showed that nanoparticles down-regulated the expression of P-glycolprotein (P-gp) on MCF-7/ADR cells and thereby improved the anticancer efficacy of PTX against MCF-7/ADR cells. Moreover, NIR laser irradiation could induce nanoparticles to generate cellular reactive oxygen species (ROS), leading to mitochondrial membrane potential loss, and meanwhile facilitating lysosomal escape of drugs. Importantly, the novel nanoplatform exhibited effective in vivo MDR inhibition and anti-metastasis efficacy through enhanced chemo-photodynamic therapy. Thus, the study suggested that the multifunctional nanoplatform had good application prospect for effective breast cancer therapy.
- Is Part Of:
- Carbohydrate polymers. Volume 254(2021)
- Journal:
- Carbohydrate polymers
- Issue:
- Volume 254(2021)
- Issue Display:
- Volume 254, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 254
- Issue:
- 2021
- Issue Sort Value:
- 2021-0254-2021-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-02-15
- Subjects:
- Multidrug resistance -- Chemo-photodynamic therapy -- Anti-metastasis -- Chemosensitizer -- Reactive oxygen species -- Chondroitin sulfate
Polysaccharides -- Periodicals
Polysaccharides -- Periodicals
Polysaccharides -- Périodiques
Electronic journals
547.78 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01448617 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.carbpol.2020.117459 ↗
- Languages:
- English
- ISSNs:
- 0144-8617
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3050.990480
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23786.xml